President Trump's new pharmaceutical tariff policy throws another wrench into an already increasingly complex drug supply chain, with experts calling for more clarity and details into the White House's new policy set to go into effect in less than a week. In announcing that branded or patented drugs would be hit with 100% tariffs on Oct. 1, Trump also said drugmakers could escape the penalties if they have a U.S.-based pharmaceutical manufacturing plant for which ground has been broken, or is currently under construction.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
